Press

  1. Towers Watson Launches Canadian Rx Coalition – A First of Its Kind Employer Alliance to Transform the $14 Billion Pharmacy Benefit Industry

    As governments scramble to reform the prescription drug market in Canada, Towers Watson today announced the launch of the Canadian Rx Coalition, a ground-breaking new way for employers to manage employee drug plans through a cooperative alliance with other Canadian plan sponsors.

    |Canada-English|

  2. Deal Makers Continue to Outperform the Market, Says Towers Watson’s Quarterly Deal Performance Monitor

    Companies that completed deals during the first quarter of 2010 outperformed the market, according to Towers Watson’s Quarterly Deal Performance Monitor. The results show that M&A deals are continuing to create rather than destroy value.

    |Canada-English|

  3. Employers Taking Action to Address Pension Costs, Towers Watson Survey Finds

    A vast majority of Canadian employers are taking steps to address the ongoing funding crisis facing their defined benefit (DB) pension plans, according to a new survey from Towers Watson, a global professional services company. The majority of employers surveyed also believe the pension funding crisis is likely to remain beyond the next few years.

    |Canada-English|Comments

  4. Wanted: Career Monogamy — Employees Seek Long-Term Relationships With Employers, According to New Towers Watson Study

    The ‘Great Recession’ may have ended, but its impact on the views of the Canadian workforce may, quite literally, be life-long, according to the results of new research from global professional services company Towers Watson. The Global Workforce Study – a biennial survey of employee attitudes and workplace trends – confirms that the recession has altered the way employees view their work today.

    |Canada-English|

  5. Towers Perrin and Watson Wyatt Complete Merger to Form Towers Watson

    Towers Watson & Co. announced today the completion of the merger of Towers Perrin and Watson Wyatt. The transaction to form Towers Watson, a leading global professional services company, was announced on June 28, 2009. Watson Wyatt Chief Executive Officer John Haley will serve as Towers Watson’s Chairman and Chief Executive Officer; Towers Perrin Chief Executive Officer Mark Mactas will serve as Deputy Chairman, President and Chief Operating Officer.

    |Global|

  6. Towers Perrin/Watson Wyatt Announce Shareholder Approval of Merger

    Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW), both leading global consulting firms, announced that at their respective special meetings of shareholders, each held earlier today, their shareholders adopted the merger agreement pursuant to which the companies will combine their businesses.

    |Global|

  7. Towers Perrin/Watson Wyatt Merger Cleared by European Commission

    Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW), both leading global consulting firms, today announced that they have been granted conditional clearance from the European Commission to allow the Parties to proceed with their merger to form Towers Watson & Co. U.S. antitrust authorities previously cleared the transaction.

    |Global|

  8. Towers Perrin and Watson Wyatt File Form S-4 as Part of Next Step in Creation of Towers Watson & Co.

    Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW) today announced that Jupiter Saturn Holding Company (“Jupiter Saturn”), the new entity formed as part of the merger process between Towers Perrin and Watson Wyatt, filed a registration statement on Form S-4 with the Securities and Exchange Commission.

    |Global|

  9. Towers Perrin and Watson Wyatt to Combine to Form Towers Watson

    Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW) today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which Towers Perrin and Watson Wyatt will combine in a merger of equals to form a new, publicly listed company called Towers Watson & Co.

    |Global|